Royal Bank of Canada
EVFM

Royal Bank of Canada’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Royal Bank of Canada’s Portfolio EVFM Stock Details EVFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,200
Closed -$1K – 8272
2022
Q2 		$1K Sell
1,200
-33
-3% -$54 ﹤0.01% 7297
2022
Q1 		$6K Buy
1,233
+1,200
+3,636% +$7.55K ﹤0.01% 7232
2021
Q4 		$0 Sell
33
-2
-6% -$17 ﹤0.01% 8199
2021
Q3 		$0 Sell
35
-1,107
-97% -$13.9K ﹤0.01% 8092
2021
Q2 		$19K Buy
1,142
+517
+83% +$9.8K ﹤0.01% 6601
2021
Q1 		$17K Sell
625
-196
-24% -$8.91K ﹤0.01% 6547
2020
Q4 		$30K Buy
821
+286
+53% +$10.3K ﹤0.01% 5892
2020
Q3 		$19K Sell
535
-39
-7% -$1.7K ﹤0.01% 5725
2020
Q2 		$24K Buy
574
+476
+486% +$32.1K ﹤0.01% 5528
2020
Q1 		$8K Sell
98
-1
-1% -$80 ﹤0.01% 5918
2019
Q4 		$9K Buy
99
+64
+183% +$5.4K ﹤0.01% 6202
2019
Q3 		$3K Buy
35
+2
+6% +$154 ﹤0.01% 6241
2019
Q2 		$3K Sell
33
-34
-51% -$2.63K ﹤0.01% 6520
2019
Q1 		$4K Hold
67
– – ﹤0.01% 6378
2018
Q4 		$4K Hold
67
– – ﹤0.01% 6279
2018
Q3 		$4K Hold
67
– – ﹤0.01% 6370
2018
Q2 		$3K Buy
67
+49
+272% +$3.85K ﹤0.01% 6206
2018
Q1 		$2K Buy
18
+7
+64% +$898 ﹤0.01% 6148
2017
Q4 		$2K Buy
+11
New +$1.24K ﹤0.01% 6321
2017
Q3 		– Hold
0
– – – 7106
2017
Q2 		– Hold
0
– – – 6886
2017
Q1 		– Sell
-6
Closed -$779 – 6911
2016
Q4 		$0 Hold
6
– – ﹤0.01% 6856
2016
Q3 		$0 Hold
6
– – ﹤0.01% 6655
2016
Q2 		$0 Buy
6
+2
+50% +$179 ﹤0.01% 6601
2016
Q1 		$0 Hold
4
– – ﹤0.01% 6768
2015
Q4 		$1K Sell
4
-6
-60% -$3.96K ﹤0.01% 6521
2015
Q3 		$7K Buy
+10
New +$10.7K ﹤0.01% 6064

Other funds holding EVFM

CS
Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Royal Bank of Canada's EVFM Position: Q3 2022 in Review

Royal Bank of Canada sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q3 2022, closing a stake of 1,200 shares — an estimated $1K sold.

Royal Bank of Canada first reported a position in EVFM in Q3 2015 and held it in 25 quarters. The position peaked at $30K in Q4 2020. 8 funds tracked by Wall St. Rank hold EVFM as of Q3 2022.

  • Royal Bank of Canada reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Royal Bank of Canada sold 1,200 Evofem Biosciences, Inc. Common Stock shares in Q3 2022, an estimated $1K.
  • Royal Bank of Canada first reported a position in Evofem Biosciences, Inc. Common Stock in Q3 2015 and held it in 25 quarters.
  • Royal Bank of Canada's Evofem Biosciences, Inc. Common Stock position peaked at $30K in Q4 2020.
  • 8 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q3 2022.

Based on Royal Bank of Canada's 13F filing for Q3 2022, filed 14 Nov 2022.